FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

356611000001102: Urispas 200 tablets (Shire Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17116301000001111 Urispas 200 tablets (Shire Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58153001000001110 Urispas 200 tablets (Recordati Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Urispas 200 tablets (Shire Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) Is a Product containing precisely flavoxate hydrochloride 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) Has active ingredient Flavoxate hydrochloride false Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) Is a Urispas true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) Has specific active ingredient Flavoxate hydrochloride true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Urispas 200 tablets (Shire Pharmaceuticals Ltd) 90 tablet Is pack of False Urispas 200 tablets (Shire Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Urispas 200 tablets (Shire Pharmaceuticals Ltd) 90 tablet Has AMP True Urispas 200 tablets (Shire Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start